The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical predictors of longer survival in patients with BRAFV600-mutated metastatic melanoma receiving immunotherapy prior to BRAF/MEK inhibition in the metastatic setting.
 
Adriana Matutino Kahn
No Relationships to Disclose
 
Curtis Perry
Stock and Other Ownership Interests - Celularity
 
Katrina Etts
Employment - Stony Brook Medicine; Stony Brook Medicine (I)
Stock and Other Ownership Interests - Amarin Corporation; Avantor; Cassava Sciences; Catalyst Pharmaceuticals; crispr therapeutics; Sarepta Therapeutics; Takeda; Zynerba
 
Harriet M. Kluger
Consulting or Advisory Role - Bristol-Myers Squibb; Calithera Biosciences; Celldex; ChemoCentryx; Clinigen Group; ElevateBio; ElevateBio; GI Reviewers; Gigagen; Instil Bio; Iovance Biotherapeutics; Merck; Shionogi; Signatera
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Apexigen
 
Mario Sznol
Stock and Other Ownership Interests - Actym Therapeutics; Adaptive Biotechnologies; Amphivena; EvolveImmune Therapeutics; GlaxoSmithKline; Intensity Therapeutics; Johnson & Johnson/Janssen; Nextcure; Torque
Consulting or Advisory Role - Abbvie; Adaptimmune; Agenus; Alligator Bioscience; Anaeropharma; AstraZeneca/MedImmune; BioNTech; Boehringer Ingelheim; Boston Pharmaceuticals; Bristol-Myers Squibb; Dragonfly Therapeutics; Genentech/Roche; Genocea Biosciences; Gilead Sciences; immunocore; Innate Pharma; ITeos Therapeutics; Jazz Pharmaceuticals; Lilly; Molecular Partners; Nektar; Numab; OncoSec; Pfizer; Pieris Pharmaceuticals; Pierre Fabre; Sapience Therapeutics; Seagen; SERVIER; Simcha Therapeutics; ST Cube; Targovax; Tessa Therapeutics; Trillium Therapeutics; Verastem; Zelluna
Other Relationship - CEC Oncology; Dava Oncology; Haymarket Media; Physicans' Education Resource